Experimentally induced rodent models of type 2 diabetes

Methods in Molecular Biology

Volumn 933, Issue , 2012, Pages 161-174

  Islam, Md Shahidul ^a   Wilson, Rachel Dorothy ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Alloxan; Fructose; High fat diet; Intrauterine growth retardation; Monosodium glutamate; Nicotinamide; Streptozotocin

Indexed keywords

FRUCTOSE; GLUTAMATE SODIUM; NICOTINAMIDE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; INTRAUTERINE GROWTH RETARDATION; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS RESECTION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 84934438487     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-68-7_10     Document Type: Article

References (53)

1. World Health Organization (2010). Facts and figures about diabetes. http://www.who.int/ diabetes/facts/en/ Accessed 5 Dec 2011
2. Pinhas-Hamiel O, Zeitler O (2005) The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 146:693-700
3. Moore KR et al (2003) Three-year prevalence and incidence of diabetes among American Indian youth in Montana and Wyoming 1999 to 2001. J Pediatr 143:368-371
4. Krosnick A (2000) The diabetes and obesity epidemic among the Pima Indians. N J Med 97:31-37
5. Srinivasan K et al (2005) Combination of high-fat diet-fed and low-dose streptozotocintreated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313-320
6. Wall RJ, Shani M (2008) Are animal models as good as we think? Theriogenology 69:2-9
7. Islam MS, Loots DT (2009) Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol 31: 249-261
8. Goldner MG, Gomori G (1943) Alloxan diabetes in the dog. Endocrinology 33:297-308
9. Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22:485-518
10. Rees DA, Alcolado JC (2005) Animal models of diabetes mellitus. Diabet Med 22:359-370
11. Bolzan AD, Bianchi MS (2002) Genotoxicity of streptozotocin. Mutat Res 512:121-134
12. Portha B et al (1974) Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes 23:889-895
13. Portha B, Picon L, Rosselin G (1979) Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17:371-377
14. Iwase M et al (1986) A new model of type 2 (non-insulin-dependent) diabetes mellitus in spontaneously hypertensive rats: diabetes induced by neonatal streptozotocin injection. Diabetologia 29:808-811
15. Giddings SJ et al (1985) Impaired insulin biosynthetic capacity in a rat model for non-insulin- dependent diabetes. Studies with dexamethasone. Diabetes 34:235-240
16. Shinde UA, Goyal RK (2003) Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J Cell Mol Med 7:322-329
17. Kodama T et al (1993) A new diabetes model induced by neonatal alloxan treatment in rats. Diabetes Res Clin Pract 20:183-189
18. Iwase M (1991) A new animal model of noninsulin dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats. Fukuoka Igaku Zasshi 82:415-427
19. Pauls F, Bancroft RW (1949) Production of diabetes in the mouse by partial pancreatectomy. Am J Physiol 160:103-106
20. Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71:1544-1553
21. Masiello P (2006) Animal models of type 2 diabetes with reduced pancreatic -cell mass. Int J Biochem Cell Biol 38:873-893
22. Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: an overview. Indian J Med Res 125:451-472
23. Kurup S, Bhonde RR (2000) Combined effect of nicotinamide and streptozotocin on diabetic status in partially pancreatectomized adult BALB/c mice. Horm Metab Res 32:330-334
24. Surwit RS et al (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37: 1163-1167
25. Winzel MS, Ahren B (2004) The high-fat dietfed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53:S215-S219
26. Kobayashi M et al (2004) Characterization of diabetes-related traits in MSM and JF1 mice on high-fat diet. J Nutr Biochem 15:614-621
27. Reuter TY (2007) Diet-induced models for obesity and type 2 diabetes. Drug Discov Today Dis Models 4:3-8
28. Chang S et al (1990) Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 259:R1103-R1110
29. Zavaroni I et al (1980) Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29:970-973
30. Tobey TA et al (1982) Mechanism of insulin resistance in fructose-fed rats. Metabolism 31:608-612
31. Dai S et al (1994) Fructose-loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats. Can J Physiol Pharmacol 72:771-781
32. Benado M et al (2004) Effects of various levels of dietary fructose on blood lipids in rats. Nutr Res 24:565-571
33. Trujillo ME, Scherer PE (2006) Adipose tissue- derived factors: impact on health and disease. Endocr Rev 27:762-778
34. Barnes KM, Miner JL (2009) Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci 10:96-107
35. Houssay BA, Martinez C (1947) Experimental diabetes and diet. Science 105:548-549
36. Chen D, Wang M-W (2005) Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7: 307-317
37. Reed MJ et al (2000) A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49:1390-1394
38. Zhang M et al (2008) The characterization of high-fat and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008:7074045. doi: 10.1155/ 2008/704045
39. Masiello P et al (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47:224-229
40. Nakamura T et al (2006) Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide. Biol Pharm Bull 29:1167-1174
41. Jinap S, Hajeb P (2010) Glutamate: its applications in food and contribution to health. Appetite 55:1-10
42. Lengvari I (1977) Effect of perinatal monosodium glutamate treatment on endocrine functions of rats in maturity. Acta Biol Acad Sci Hung 28:133-141
43. Hirata AE et al (1997) Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 30: 671-674
44. Iwase M et al (1998) Obesity induced by neonatal monosodium glutamate treatment in spontaneously hypertensive rats: an animal model of multiple risk factors. Hypertens Res 21:1-6
45. Ito M et al (1999) New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin. Biol Pharm Bull 22:988-989
46. Ribeiro EB et al (1997) Hormonal and metabolic adaptations to fasting in monosodium glutamate-obese rats. J Comp Physiol B 167: 430-437
47. Morrison JFB et al (2007) Sensory and autonomic nerve changes in the monosodium glutamate- treated rat: a model of type II diabetes. Exp Physiol 93:213-222
48. Nagata M et al (2006) Type 2 diabetes mellitus in obese model induced by monosodium glutamate. Exp Anim 55:109-115
49. Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50:2279-2286
50. Vuguin P et al (2004) Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Diabetes 53:2617-2622
51. Barker DJP et al (1993) Type 2 (non-insulindependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67
52. Peterside IE, Selak MA, Simmons RA (2003) Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats. Am J Physiol Endocrinol Metab 285: E1258-E1266
53. Hales CN et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019-1022